Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

Safety versus Speed in Drug Development

The heightened focus on risk raises concerns about delays in approving new drugs.
Nov 2, 2009

The heightened focus on risk raises concerns about delays in approving new drugs.

New Leadership Seeks to Transform FDA

Strict enforcement, new rules, and organizational changes signal an activist tone.
Oct 2, 2009

Strict enforcement, new rules, and organizational changes signal an activist tone.

Global Health Concerns Create Business Opportunities

Health crises generate support for new vaccines and treatments for diseases found in developing nations.
Sep 2, 2009

Health crises generate support for new vaccines and treatments for diseases found in developing nations.

Pharma Girds for Healthcare Reform

Pressure to reduce healthcare spending has put drug rebates, price cuts, and tax hikes on the table.
Aug 2, 2009

Pressure to reduce healthcare spending has put drug rebates, price cuts, and tax hikes on the table.

Manufacturers Face New Risk-Management Requirements

REMS to improve the safe use of opioids may lead to controls on other high-risk medicines.
Jul 2, 2009

REMS to improve the safe use of opioids may lead to controls on other high-risk medicines.

FDA Commissioner Hamburg Discusses Drug Regulation

Jun 22, 2009

The new commissioner of the US Food and Drug Administration is mapping plans for turning around an agency that has been demoralized, buffeted about in the press and has lost some of the trust of the American people.

FDA Waves a Big Stick

Agency officials and manufacturers anticipate stricter enforcement of drug safety and quality.
Jun 2, 2009

Agency officials and manufacturers anticipate stricter enforcement of drug safety and quality.

The Comparative-Effectiveness Controversy

Government funding is slated to boost comparative studies of prescription drugs.
May 2, 2009

Government funding is slated to boost comparative studies of prescription drugs.

Downpayment on Health Reform

President Obama's economic recovery plain includes goals such as reducing the number of uninsured citizens and improving the quality of healthcare.
Apr 2, 2009

President Obama's economic recovery plain includes goals such as reducing the number of uninsured citizens and improving the quality of healthcare.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here